treatment adherence

Patient-Specific Pessaries After Suboptimal Outcomes With Standard Pessary Use: A Multicenter Retrospective Case Series

By MedXY 10/06/2026

This retrospective case series evaluates patient-specific pessaries' success in individuals with prior suboptimal outcomes using standard pessaries for pelvic organ prolapse across Canadian clinical sites.

Diabetes & Endocrinology news Psychiatry

Navigating Gender-Affirming Hormone Therapy in Autistic Transgender and Gender Diverse Adults: Challenges and Strategies for Optimal Adherence

By MedXY 09/11/2026

This article explores the unique challenges autistic transgender and gender diverse adults face in adhering to gender-affirming hormone therapy (GAHT) and highlights strategies to support effective therapy adherence in clinical endocrinology settings.

news OB/GYN & Women's Health OB/GYN & Women’s Health

Disparities and Persistence in Systemic Hormone Therapy Among Menopausal Women: Insights from a Large Real-World Analysis

By MedXY 07/31/2026

A comprehensive study reveals initiation rates, duration, and racial disparities in systemic hormone therapy use among menopausal women, emphasizing critical care gaps and the need for equitable interventions.

news OB/GYN & Women's Health Oncology Specialties

Impact of Treatment Recommendation and Receipt on Survival in Older Women with Early-Stage Cervical Cancer

By MedXY 09/24/2025

This study reveals that among women aged 65 and older with early-stage cervical cancer, those who receive recommended treatment—surgery and/or radiotherapy—exhibit significantly higher survival rates, emphasizing the need to overcome treatment barriers in this population.

news Otorhinolaryngology Specialties

High Adherence to Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Insights from Real-World US Data

By MedXY 08/21/2025

Real-world analysis of 3318 US patients with CRSwNP treated with dupilumab demonstrated high persistence and adherence at 12 months, with significant rates of treatment reinitiation after discontinuation, underscoring dupilumab's sustained use in clinical practice.